JPRN-jRCT1050220190
Not yet recruiting
未知
Effects of SGLT2 inhibitors on appetite in patients with type 2 diabetes
in Kazuko0 sites58 target enrollmentMarch 14, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- in Kazuko
- Enrollment
- 58
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Those with a diagnosis of type 2 diabetes
- •2\) Persons starting SGLT2 inhibitors
- •3\) Patients between 20 and 85 years of age
- •4\) Patients with renal function eGFR 30 or higher
- •5\) BMI of 18\.5 or more
Exclusion Criteria
- •1\) Those undergoing treatment for cancer
- •2\) Pregnant women
- •3\) Those who are emotionally unstable due to mental illness, etc. and have difficulty participating in the research
- •4\) Those who have difficulty in reading and understanding Japanese
- •5\) Persons with dementia
- •6\) Those who are judged by the attending physician or researcher to be unable to participate in the research.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
SEESAW (SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation)Type 2 diabetes mellitusMedDRA version: 21.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2015-001594-40-GBniversity of Leicester76
Completed
Phase 4
The effects of empagliflozin on appetite and weight regulation in diabeticsSpecialty: Diabetes, Primary sub-specialty: BothUKCRC code/ Disease: Metabolic/ Diabetes mellitus, Metabolic/ Diabetes mellitusNutritional, Metabolic, EndocrineDiabetes mellitusISRCTN82062639niversity of Leicester68
Completed
Not Applicable
Efficacy and change in taste by taking SGLT2 inhibitor in patients with type 2 diabetestype 2 diabetesJPRN-UMIN000020157agasaki University Hospital60
Completed
Not Applicable
Effect of SGLT2 inhibitor on energy metabolism in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000024822Kyoto University Graduate School of Medicine100
Completed
Not Applicable
A study on the efficacy and biogenic adaptability affected by ipraglifloziType 2 diabetesJPRN-UMIN000015478Kobe University104